thiophenes has been researched along with Peripheral Vascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ng, HJ; Teo, EC; Than, H | 1 |
| Hess, C | 1 |
| Asai, F; Hashimoto, M; Jakubowski, JA; Niitsu, Y; Ogawa, T; Otsuguro, K; Sugidachi, A; Tani, Y | 1 |
3 other study(ies) available for thiophenes and Peripheral Vascular Diseases
| Article | Year |
|---|---|
First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.
Topics: Aged; Blood Coagulation; Factor Xa Inhibitors; Female; Heparin; Heparin Antagonists; Humans; Kidney Failure, Chronic; Male; Middle Aged; Morpholines; Peripheral Vascular Diseases; Platelet Count; Renal Dialysis; Rivaroxaban; Thiophenes; Thrombocytopenia; Venous Thrombosis | 2015 |
[Always more amputations in Germany?].
Topics: Aged; Amputation, Surgical; Anticoagulants; Arterial Occlusive Diseases; Benzimidazoles; Dabigatran; Fibrinolytic Agents; Germany; Humans; Morpholines; Peripheral Vascular Diseases; Pyridines; Rivaroxaban; Thiophenes; Thrombosis | 2008 |
Effects of prasugrel, a novel P2Y(12) inhibitor, in rat models of cerebral and peripheral artery occlusive diseases.
Topics: Animals; Cerebral Arterial Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Peripheral Vascular Diseases; Piperazines; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Thiophenes | 2009 |